Eddie Pan

Eddie Pan

Expertise: Institutional Investments, Insider Activity, Disruptive Innovations

Education: BBA, Finance, James Madison University

About Eddie:
Eddie Pan specializes in institutional investments and insider activity. He has been enamored with hedge funds since he began investing and regularly collaborates with industry executives to craft editorial pieces. Tracking the investments of institutional investors and insiders can provide a vast array of knowledge that is scarcely covered.

After receiving his BBA in Finance from James Madison University, Eddie began his career at Accenture as an analyst. Today, he writes for InvestorPlace’s Today’s Market team, which centers on the latest news involving popular stocks.

Eddie got his start in the financial media world by publishing articles on top-performing hedge funds and their investment strategies on Substack. He still publishes pieces on his Substack today.

Common Stocks and Uncommon Profits by Philip A. Fisher is Eddie’s favorite investment book. Fisher’s 15 Points have heavily influenced his investment strategy.

Recent Articles

TSLA Stock Starts to Rev Up on Berlin Gigafactory Approval

Shares of TSLA stock are outperforming the market after the EV company received conditional approval for its Brandenburg gigafactory.

Watch Out, Reddit. Here’s How Commonstock Plans to Transform Stock Message Boards.

Commonstock CEO David McDonough sees his company revolutionizing the way retail investors engage on social media.

Why Is Veon (VEON) Stock Up Today?

Despite VEON stock's exorbitant gains today, the connectivity provider is still down more than 70% year-to-date. Here's what's next for Veon.

4 Commodity ETFs to Watch: Why Are CORN, DBA, SOYB, WEAT ETFs on the Move Today?

In light of the Russia-Ukraine conflict, commodity prices around the world may see a spike. CORN, DBA, SOYB, WEAT ETFs are all worth watching.

Why Is Ocugen (OCGN) Stock Down Today?

Shares of OCGN stock are in the red after the company's Covaxin Covid-19 vaccine was declined EUA by the FDA. Here's what you should know.